109220 ⎘
Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
APTAMER DISCOVERY AND SELECTION TECHNIQUES
#2COMPOUNDS FOR INHIBITING THE INTERACTION OF SARS-COV2 WITH HUMAN PROTEIN ACE2
#3METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR APTAMER SELECTION
#4Anti-Fibrinogen Aptamers
#5APTAMERS FOR DETECTING VARIANTS OF A TARGET ANALYTE, METHODS OF MAKING AND USES THEREOF
#6Nucleic Acid Compounds That Bind Coronavirus Proteins
#7GENERATION OF NOVEL CRISPR GENOME EDITING AGENTS USING COMBINATORIAL CHEMISTRY
#8PROCESS FOR SELECTION OF APTAMERS, RIBOSWITCHES AND DESOXYRIBOSWITCHES
#9CONVERSION OF STRAND DISPLACEMENT APTAMERS INTO MOLECULAR BEACONS
#10CYTOTOXIC T-LYMPHOCYTE BINDING APTAMERS
#11Compositions and Methods Relating to Synthetic RNA Polynucleotides Created From Synthetic DNA Oligonucleotides
#12METHOD OF DETECTION OF FIBRIN CLOTS
#13SYSTEMS AND METHODS FOR DETECTING A PATHOGENIC ORGANISM
#14Nucleic acid aptamer for influenza virus and detection of influenza virus
#15APTAMERS AGAINST IMATINIB
#16METHODS AND COMPOSITIONS FOR SELECTION OF FUNCTIONAL APTAMERS
#17METHOD OF SEQUENCING NUCLEIC ACID WITH UNNATURAL BASE PAIRS
#18Anti-fibrinogen aptamers
#19NOVEL DNA APTAMER AND USE THEREOF
#20TARGETED MUTAGENESIS USING BASE EDITORS
#21APTAMERS AND USES THEREOF
#22Astrocyte-specific nucleic acid aptamer and use thereof
#23Compositions and methods involving non-natural aptamer libraries
#24METHOD OF IDENTIFYING OR PRODUCING AN APTAMER FOR A DENATURED PEPTIDE OR PROTEIN
#25Aptamer-based CAR T-cell switch
#26COMPOSITIONS FOR SELECTION OF APTAMERS
#27NUCLEIC ACID APTAMERS
#28Nucleic acid based biosensor and methods thereof
#29Functional ligands to LL37
#30Compositions for Selection of Aptamers
#31Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
#32Aptamers and uses thereof
#33Methods and Compositions for Selecting siRNA of Improved Functionality
#34TARGETED MUTAGENESIS
#35Method for Obtaining Aptamers
#36Materials and methods for rapid and specific detection of synthetic cathinones
#37Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides
#38Aptamer methods and compositions
#39Nucleic acid aptamers
#40DNA aptamer binding to cancer cell
#41Method and kit for analyte detection
#42Methods and compositions for selecting siRNA of improved functionality
#43Methods and compositions for selecting siRNA of improved functionality
#44Multiaptamer target detection
#45Functional ligands to chikungunya envelope proteins
#46Catalytic strands of minimal hammerhead ribozymes and methods of using the same
#47FUNCTIONAL LIGANDS TO THC
#48Structure assisted directed evolution of multivalent aptamers
#49Methods and Compositions for Selecting siRNA of Improved Functionality
#50Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides
#51Method for affinity purification
#52Specific oligonucleotide aptamer for the identification of T-2 toxin
#53Rapid in situ testing for environmental contamination
#54Nucleic acid fragment binding to target protein
#55Method for preparing nucleic acid aptamer
#56Multiaptamer target detection
#57Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method
#58Methods and compositions for selecting siRNA of improved functionality
#59Microbial consortia for programmable output via photoautotroph-heterotroph interactions
#60Methods and compositions for selecting siRNA of improved functionality
#61Methods and compositions for selecting siRNA of improved functionality
#62Aptamers and use of the aptamers in the diagnosis and treatment of cancer
#63Screening of nucleic acid agents via particle display
#64Aptamer methods and compositions
#65Aptamers and uses thereof
#66Method for screening for high L-tryptophan producing microorganisms using riboswitch
#67Aptamers, multimeric aptamers and uses thereof
#68RNA APTAMER ISOLATION VIA DUAL-CYCLE (RAPID) SELECTION
#69Nucleic acid fragment binding to target protein
#70Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method
#71Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
#72Switchable aptamers
#73Ketol-acid reductoisomerase using NADH
#74Subunit-selective nucleic acid inhibitors of glutamate receptors
#75Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same
#76Methods for identifying nucleic acid ligands
#77Methods of preparing targeted aptamer prodrugs
#78Methods for identifying nucleic acid ligands
#79NON HUMAN ANIMAL MODELS FOR INCREASED RETINAL VASCULAR PERMEABILITY
#80DNA nanostructures that promote cell-cell interaction and use thereof
#81DIRECT SELECTION OF STRUCTURALLY DEFINED APTAMERS
#82Lariat aptamer: aptamer candidate exclusion by nuclease digestion
#83Method for obtaining oligonucleotide aptamers and uses thereof
#84Methods for identifying nucleic acid ligands
#85Ketol-acid reductoisomerase using NADH
#86OLIGONUCLEOTIDE SYSTEMS FOR TARGETED INTRACELLULAR DELIVERY
#87Evolved orthogonal ribosomes
#88Focused libraries, functional profiling, laser SELEX, and DESELEX
#89DEVICE AND SUBSTANCE FOR THE IMMOBILIZATION OF MESENCHYMAL STEM CELLS (MSCs)
#90Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics
#91Selex and photoSELEX
#92Aptamers and methods for their in vitro selection and uses thereof
#93Metabolic profile directed aptamer medicinal chemistry
#94Method of Treatment by Administration of Rna
#95Modified triple-helix forming oligonucleotides for targeted mutagenesis
#96Polynucleotides capable of target-depedent circularization and topological linkage
#97Aptamer medicinal chemistry
#98Combinatorial selection of phosphorothioate aptamers for RNases
#99Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
#100High affinity oligonucleotide ligands to growth factors
#101Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
#102Aptamers and methods for their in vitro selection and uses thereof
#103In vitro selection of aptamer beacons
#104RNA-based transcriptional regulators